rs121964965
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 7P and 1B. PM1PP3_StrongPP5BS2_Supporting
The ENST00000398165.8(CBS):c.415G>A(p.Gly139Arg) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0000095 ( 0 hom., cov: 15)
Exomes 𝑓: 0.0000095 ( 2 hom. )
Consequence
CBS
ENST00000398165.8 missense
ENST00000398165.8 missense
Scores
16
2
1
Clinical Significance
Conservation
PhyloP100: 6.84
Genes affected
CBS (HGNC:1550): (cystathionine beta-synthase) The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in ENST00000398165.8
PP3
MetaRNN computational evidence supports a deleterious effect, 0.983
PP5
Variant 21-43066279-C-T is Pathogenic according to our data. Variant chr21-43066279-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 121.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=1}. Variant chr21-43066279-C-T is described in Lovd as [Pathogenic].
BS2
High Homozygotes in GnomAdExome4 at 2 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CBS | NM_000071.3 | c.415G>A | p.Gly139Arg | missense_variant | 5/17 | ENST00000398165.8 | NP_000062.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CBS | ENST00000398165.8 | c.415G>A | p.Gly139Arg | missense_variant | 5/17 | 1 | NM_000071.3 | ENSP00000381231 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000947 AC: 1AN: 105604Hom.: 0 Cov.: 15
GnomAD3 genomes
AF:
AC:
1
AN:
105604
Hom.:
Cov.:
15
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250444Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135554
GnomAD3 exomes
AF:
AC:
7
AN:
250444
Hom.:
AF XY:
AC XY:
5
AN XY:
135554
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000949 AC: 10AN: 1054038Hom.: 2 Cov.: 19 AF XY: 0.0000131 AC XY: 7AN XY: 534946
GnomAD4 exome
AF:
AC:
10
AN:
1054038
Hom.:
Cov.:
19
AF XY:
AC XY:
7
AN XY:
534946
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000947 AC: 1AN: 105640Hom.: 0 Cov.: 15 AF XY: 0.0000195 AC XY: 1AN XY: 51278
GnomAD4 genome
AF:
AC:
1
AN:
105640
Hom.:
Cov.:
15
AF XY:
AC XY:
1
AN XY:
51278
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
5
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Homocystinuria, pyridoxine-responsive Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 1995 | - - |
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 139 of the CBS protein (p.Gly139Arg). This variant is present in population databases (rs121964965, gnomAD 0.01%). This missense change has been observed in individual(s) with homocystinuria due to CBS deficiency (PMID: 7611293). ClinVar contains an entry for this variant (Variation ID: 121). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CBS protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects CBS function (PMID: 22267502). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 06, 2022 | Variant summary: CBS c.415G>A (p.Gly139Arg) results in a non-conservative amino acid change located in the Tryptophan synthase beta chain-like, PALP domain (IPR001926) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 250444 control chromosomes (gnomAD). c.415G>A has been reported in the literature in at least one compound heterozygous individual affected with Homocystinuria (Shih_1995). These data do not allow any conclusion about variant significance. One publication using a yeast ortholog replacement assay reports experimental evidence indicating the variant has an intermediate phenotype that is responsive to B6 supplementation (Mayfield_2012). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;D;D;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;.;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;H;H;H;.
MutationTaster
Benign
A;A;A;A;A;A;A;A;A;A;A;A
PrimateAI
Pathogenic
T
PROVEAN
Pathogenic
D;D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D
Polyphen
D;D;D;D;.
Vest4
MutPred
Gain of phosphorylation at T141 (P = 0.0948);Gain of phosphorylation at T141 (P = 0.0948);Gain of phosphorylation at T141 (P = 0.0948);Gain of phosphorylation at T141 (P = 0.0948);Gain of phosphorylation at T141 (P = 0.0948);
MVP
MPC
1.2
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at